Your browser doesn't support javascript.
loading
A comparative study of peri-operative outcomes for 100 consecutive post-chemotherapy and primary robot-assisted and open retroperitoneal lymph node dissections.
Lloyd, Paul; Hong, Anne; Furrer, Marc A; Lee, Elaine W Y; Dev, Harveer S; Coret, Maurice H; Adshead, James M; Baldwin, Peter; Knight, Richard; Shamash, Jonathan; Alifrangis, Constantine; Stoneham, Sara; Mazhar, Danish; Wong, Han; Warren, Anne; Tran, Ben; Lawrentschuk, Nathan; Neal, David E; Thomas, Benjamin C.
Afiliación
  • Lloyd P; Department of Urology, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, UK.
  • Hong A; Department of Urology, Royal Melbourne Hospital, Melbourne, Australia.
  • Furrer MA; Department of Urology, Royal Melbourne Hospital, Melbourne, Australia.
  • Lee EWY; Department of Urology, University Hospital of Bern, Bern, Switzerland.
  • Dev HS; The Australian Medical Robotics Academy, Melbourne, Australia.
  • Coret MH; Department of Urology, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, UK.
  • Adshead JM; Department of Urology, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, UK.
  • Baldwin P; Department of Urology, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, UK.
  • Knight R; Department of Urology, Lister Hospital, Stevenage, UK.
  • Shamash J; Department of Gynae-Oncology, Addenbrooke's Hospital, Cambridge, UK.
  • Alifrangis C; Department of Urology, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, UK.
  • Stoneham S; Department of Oncology, St Bartholomew's Hospital, London, UK.
  • Mazhar D; Department of Oncology, University College London Hospital, London, UK.
  • Wong H; Department of Oncology, University College London Hospital, London, UK.
  • Warren A; Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, UK.
  • Tran B; Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, UK.
  • Lawrentschuk N; Department of Pathology, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, UK.
  • Neal DE; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Thomas BC; Department of Oncology, University of Melbourne, Melbourne, Australia.
World J Urol ; 40(1): 119-126, 2022 Jan.
Article en En | MEDLINE | ID: mdl-34599350
ABSTRACT

PURPOSE:

To describe and compare differences in peri-operative outcomes of robot-assisted (RA-RPLND) and open (O-RPLND) retroperitoneal lymph node dissection performed by a single surgeon where chemotherapy is the standard initial treatment for Stage 2 or greater non-seminomatous germ cell tumour.

METHODS:

Review of a prospective database of all RA-RPLNDs (28 patients) and O-RPLNDs (72 patients) performed by a single surgeon from 2014 to 2020. Peri-operative outcomes were compared for patients having RA-RPLND to all O-RPLNDs and a matched cohort of patients having O-RPLND (20 patients). Further comparison was performed between all patients in the RA-RPLND group (21 patients) and matched O-RPLND group (18 patients) who had previous chemotherapy. RA-RPLND was performed for patients suitable for a unilateral template dissection. O-RPLND was performed prior to the introduction of RA-RPLND and for patients not suitable for RA-RPLND after its introduction.

RESULTS:

RA-RPLND showed improved peri-operative outcomes compared to the matched cohort of O-RPLND-median blood loss (50 versus 400 ml, p < 0.00001), operative duration (150 versus 195 min, p = 0.023) length-of-stay (1 versus 5 days, p < 0.00001) and anejaculation (0 versus 4, p = 0.0249). There was no statistical difference in complication rates. RA-RPLND had lower median lymph node yields although not significant (9 versus 13, p = 0.070). These improved peri-operative outcomes were also seen in the post-chemotherapy RA-RPLND versus O-RPLND analysis. There were no tumour recurrences seen in either group with median follow-up of 36 months and 60 months, respectively.

CONCLUSIONS:

Post-chemotherapy RA-RPLND may have decreased blood loss, operative duration, hospital length-of-stay and anejaculation rates in selected cases and should, therefore, be considered in selected patients. Differences in oncological outcomes require longer term follow-up.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Testiculares / Neoplasias de Células Germinales y Embrionarias / Procedimientos Quirúrgicos Robotizados / Escisión del Ganglio Linfático Límite: Humans / Male Idioma: En Revista: World J Urol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Testiculares / Neoplasias de Células Germinales y Embrionarias / Procedimientos Quirúrgicos Robotizados / Escisión del Ganglio Linfático Límite: Humans / Male Idioma: En Revista: World J Urol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido